Stimcell Energetics (STME) Long-Term Debt Repayments (2017)
Stimcell Energetics' quarterly Long-Term Debt Repayments came in at $19593.0 in Q4 2017, up 529.8% quarter-over-quarter from $3111.0 in Q3 2017.
Stimcell Energetics has reported Long-Term Debt Repayments for 1 years, with the latest figure at $19593.0 in Q4 2017.
- For the quarter ending Q4 2017, Long-Term Debt Repayments changed N/A year-over-year to $19593.0; the trailing twelve-month figure through May 2018 stood at $22704.0 (changed N/A YoY), and the FY2018 full-year result was $22704.0, up 166.97% from the prior year.
- Long-Term Debt Repayments for Q4 2017 stood at $19593.0, up from $3111.0 in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $19593.0 in Q4 2017, with the low at -$31217.0 in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Stimcell Energetics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2017 | 19,593.00 |
| Nov 30, 2017 | 19,593.00 |
| Aug 31, 2017 | 3,111.00 |
| Aug 31, 2017 | 3,111.00 |
| May 31, 2017 | -31,217.00 |
| May 31, 2017 | -31,217.00 |